These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10193720)

  • 1. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of paroxetine in the treatment of refractory vasovagal syncope in young patients].
    Di Girolamo E; Di Iorio C; Leonzio L; Sabatini P; Ranalli G; Barsotti A
    G Ital Cardiol; 1999 Dec; 29(12):1472-7. PubMed ID: 10687110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents.
    Grubb BP; Samoil D; Kosinski D; Kip K; Brewster P
    J Am Coll Cardiol; 1994 Aug; 24(2):490-4. PubMed ID: 8034887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin reuptake inhibition for the prevention of vasovagal syncope: a systematic review and meta-analysis.
    Raj P; Lei L; Flevaris P; Raj S; Sheldon R
    Clin Auton Res; 2023 Dec; 33(6):811-819. PubMed ID: 37971641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants for fainting spells.
    Harv Heart Lett; 1999 Sep; 10(1):3. PubMed ID: 10445969
    [No Abstract]   [Full Text] [Related]  

  • 6. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome.
    Theodorakis GN; Markianos M; Zarvalis E; Livanis EG; Flevari P; Kremastinos DT
    J Am Coll Cardiol; 2000 Jul; 36(1):174-8. PubMed ID: 10898430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of pathophysiology and therapy of patients with vasovagal syncope.
    White CM; Tsikouris JP
    Pharmacotherapy; 2000 Feb; 20(2):158-65. PubMed ID: 10678294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasovagal syncope: asystole provoked by head-up tilt testing under sertraline therapy.
    Lenk MK; Alehan D; Ozme S; Celiker A; Ozer S
    Turk J Pediatr; 1997; 39(4):573-7. PubMed ID: 9433163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are treatments for vasovagal syncope effective? A meta-analysis.
    Vyas A; Swaminathan PD; Zimmerman MB; Olshansky B
    Int J Cardiol; 2013 Sep; 167(5):1906-11. PubMed ID: 22626839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy.
    Sra J; Maglio C; Biehl M; Dhala A; Blanck Z; Deshpande S; Jazayeri MR; Akhtar M
    J Cardiovasc Electrophysiol; 1997 Jan; 8(1):42-6. PubMed ID: 9116967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of atropine in vasovagal syncope induced by head-up tilt testing.
    Santini M; Ammirati F; Colivicchi F; Gentilucci G; Guido V
    Eur Heart J; 1999 Dec; 20(23):1745-51. PubMed ID: 10562483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study.
    Di Girolamo E; Di Iorio C; Leonzio L; Sabatini P; Barsotti A
    Circulation; 1999 Oct; 100(17):1798-801. PubMed ID: 10534467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice. Neurocardiogenic syncope.
    Grubb BP
    N Engl J Med; 2005 Mar; 352(10):1004-10. PubMed ID: 15758011
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity.
    Flevari P; Leftheriotis D; Repasos E; Katsaras D; Katsimardos A; Lekakis J
    Europace; 2017 Jan; 19(1):127-131. PubMed ID: 27702846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope.
    Baran I; Gemici K; Ozdemir B; Saraç M; Güllülü S; Aydinlar A; Cordan J
    Indian Heart J; 2003; 55(1):40-3. PubMed ID: 12760586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapy of neurocardiogenic syncope.
    Cadman CS
    Cardiol Clin; 2001 May; 19(2):203-13, v. PubMed ID: 11407106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
    Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
    Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.
    Theodorakis GN; Leftheriotis D; Livanis EG; Flevari P; Karabela G; Aggelopoulou N; Kremastinos DT
    Europace; 2006 Mar; 8(3):193-8. PubMed ID: 16627439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of serotonin re-uptake inhibitors in preventing recurrent unexplained childhood syncope -- a preliminary report.
    Lenk M; Alehan D; Ozme S; Celiker A; Ozer S
    Eur J Pediatr; 1997 Oct; 156(10):747-50. PubMed ID: 9365060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.